Hedera (HBAR) Coils in Tight Range as Technical Patterns Signal Impending Breakout
, , ,

Hedera (HBAR) Coils in Tight Range as Technical Patterns Signal Impending Breakout

Hedera (HBAR) is currently experiencing a period of intense price compression, trading within a highly restricted range as market participants await a decisive directional move. Over the last 24 hours, the digital asset has hovered between $0.0780 and $0.0803, reflecting a broader state of market equilibrium and flat short-term momentum. Despite a minor intraday uptick, […]

AbbVie Expands Immunology Dominance with $10.9 Billion Acquisition of Apogee Therapeutics
, , ,

AbbVie Expands Immunology Dominance with $10.9 Billion Acquisition of Apogee Therapeutics

In a significant move to bolster its long-term immunology pipeline, pharmaceutical giant AbbVie has announced a definitive agreement to acquire biotech firm Apogee Therapeutics for $10.9 billion. This transaction represents AbbVie’s most substantial acquisition in over five years, signaling a strategic pivot toward next-generation treatments as the company prepares for future patent expirations on its […]

The High-Stakes Battle for the Ultra-Wealthy: Why Financial Firms Are Moving Upmarket
, , ,

The High-Stakes Battle for the Ultra-Wealthy: Why Financial Firms Are Moving Upmarket

The landscape of wealth management is undergoing a significant transformation as firms increasingly pivot their strategies to capture the business of the ultra-high-net-worth demographic. Driven by a historic surge in the fortunes of the top 1% and a growing population of households with over $20 million in investable assets, financial institutions are aggressively expanding their […]